Analisis Keuangan Saham IMAB - I-Mab - Depositary Receipt (Common Stock) (NasdaqGM) Stock

Gambaran Umum

I-Mab, based in China, operates as a clinical-stage biopharmaceutical company primarily involved in the discovery, development, and potential commercialization of innovative biologics in the therapeutic area of immuno-oncology and autoimmune diseases. As a player in the biotech industry, I-Mab stands out due to its robust pipeline that includes several late-stage assets and other drug candidates in various stages of clinical trials globally. Notably, the company is committed to addressing critical unmet medical needs by advancing a wave of novel therapies, focusing on bringing pioneering treatments to patients worldwide. The strategic deployment of its resources underscores its dedication to achieving milestones in biologic therapy innovations, exemplified by its continued progression to phase III clinical trials in some candidate drugs.

Skor Kualitas, Nilai, dan Momentum

Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.

Kualitas

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Nilai

Model penilaian eksklusif yang memberi peringkat pada perusahaan berdasarkan valuasi relatifnya. Skor berkisar antara 0 hingga 100, dengan 100 sebagai yang paling diremehkan nilainya.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Sentimen Dana

Skor Sentimen Dana (sebelumnya dikenal sebagai Skor Kepemilikan) adalah model kuantitatif eksklusif yang memberi peringkat pada perusahaan berdasarkan tingkat akumulasi kepemilikan.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih

Nilai operating income untuk I-Mab - Depositary Receipt (Common Stock) per 2025 Jun 30 adalah -38.16 MM.
Nilai net income untuk I-Mab - Depositary Receipt (Common Stock) per 2025 Jun 30 adalah -37.01 MM.

Period End (TTM)	Revenue (MM)	Operating Income (MM)	Net Income (MM)
2025-06-30		-38.16	-37.01
2025-03-31		-48.19	-9.06
2024-12-31		-51.43	-22.23
2024-09-30	0.57	-78.28	-62.56
2024-06-30	3.49	-172.45	-111.78
2024-03-31	-0.73	-10.96	-170.53
2023-12-31	0.63	-48.98	-207.73
2023-09-30	12.93	32.92	-295.21
2023-06-30	-253.77	-1,725.29	-2,137.76
2023-03-31	-237.66	-1,799.63	-2,274.79
2022-12-31	-1.55	-53.08	-371.05
2022-09-30	-49.73	-1,926.26	-2,404.62
2022-06-30	122.11	-1,874.05	-2,301.92
2022-03-31	105.07	-1,972.68	-2,316.73
2021-12-31	88.03	-2,071.31	-2,331.54
2021-09-30	1,595.57	-375.21	-662.46
2021-06-30	1,560.44	-248.47	-22.71
2021-03-31	1,551.56	-46.45	224.10
2020-12-31	1,542.67	155.57	470.92
2020-09-30	0.00	-1,343.10	-919.21

Laporan Laba Rugi: EPS

Period End (TTM)	Earnings Per Share Basic	Earnings Per Share Diluted
2025-06-30
2025-03-31	-0.11	-0.11
2024-12-31	-0.28
2024-09-30	-0.77	-0.77
2024-06-30	-1.36	-1.36
2024-03-31	-2.06	-2.06
2023-12-31	-2.51
2023-09-30	-3.55	-3.55
2023-06-30	-25.75	-25.75
2023-03-31	-27.48	-27.49
2022-12-31	-4.51
2022-09-30	-29.54	-29.54
2022-06-30	-28.66	-28.67
2022-03-31	-29.65	-29.66
2021-12-31	-30.69	-30.70
2021-09-30	-9.03	-9.03
2021-06-30	-0.33	-0.32
2021-03-31	3.53	3.06
2020-12-31	8.07	6.90
2020-09-30	-22.56	-22.56

Arus Kas: Operasi, Investasi, Pendanaan

Period End (TTM)	Cash From Operating Activities (MM)	Cash From Investing Activities (MM)	Cash From Financing Activities (MM)
2025-06-30
2025-03-31
2024-12-31	-52.67	-136.01	-0.34
2024-09-30
2024-06-30
2024-03-31
2023-12-31	-72.70	-15.16	-8.24
2023-09-30
2023-06-30
2023-03-31
2022-12-31	-49.58	-5.18	3.91
2022-09-30
2022-06-30	-1,101.61	153.52	143.06
2022-03-31	-1,037.35	-286.85	368.49
2021-12-31	-973.09	-727.21	593.92
2021-09-30	308.32	-499.81	1,384.87
2021-06-30	340.71	-613.64	3,272.93
2021-03-31	387.13	-407.77	3,356.70
2020-12-31	433.56	-201.90	3,440.48
2020-09-30	-798.62	-179.05	2,708.99

Metrik Penilaian: PE, PriceToBook, PriceToTBV

p/libro untuk I-Mab - Depositary Receipt (Common Stock) pada 2025 Jun 30 adalah 0.99.
p/tbv untuk I-Mab - Depositary Receipt (Common Stock) pada 2025 Jun 30 adalah 0.99.

P/Book: The current closing price divided by the book value per share.

P/TBV: The current price divided by the tangible book value per share.

Period End (TTM)	p/e	P/Book	P/TBV
2025-06-30		0.99	0.99
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30

Metrik Penilaian: EBitToEv, EBit3YrAvgToEv

EBIT/EV untuk I-Mab - Depositary Receipt (Common Stock) pada 2025 Jun 30 adalah -0.30.
EBIT (3 tahun) / EV untuk I-Mab - Depositary Receipt (Common Stock) pada 2025 Jun 30 adalah -5.59.

Period End (TTM)	EBIT/EV	EBIT (3y)/EV
2025-06-30	-0.30	-5.59
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30

Efektivitas Manajemen

roa untuk I-Mab - Depositary Receipt (Common Stock) pada 2025 Jun 30 adalah -0.04.
roe untuk I-Mab - Depositary Receipt (Common Stock) pada 2025 Jun 30 adalah -0.04.
roic untuk I-Mab - Depositary Receipt (Common Stock) pada 2025 Jun 30 adalah -0.04.
croic untuk I-Mab - Depositary Receipt (Common Stock) pada 2025 Jun 30 adalah -1.20.
ocroic untuk I-Mab - Depositary Receipt (Common Stock) pada 2025 Jun 30 adalah -0.26.

Period End (TTM)	ROA	ROE	ROIC (Tingkat Pengembalian Investasi Modal)	CROIC	OCROIC
2025-06-30	-0.04	-0.04	-0.04	-1.20	-0.26
2025-03-31	-0.02	-0.04	-0.26	0.00	0.00
2024-12-31	-0.03	-0.05	-0.37	0.00	0.00
2024-09-30	-0.04	-0.07	-0.46	-4.62	-5.42
2024-06-30	-0.42	-0.60	-0.82	-0.62	-0.73
2024-03-31			-0.82	0.00	0.00
2023-12-31	-0.52	-0.71	-0.10	0.00	0.00
2023-09-30	-0.43	-0.53	-0.85	0.00	0.00
2023-06-30	-0.48	-0.60	-0.85	0.00	0.00
2023-03-31	-0.48	-0.60	-0.91	0.00	0.00
2022-12-31	-0.41	-0.50	-0.77	-0.21	-0.36
2022-09-30	-0.41	-0.50	-0.77	0.00	0.00
2022-06-30	-0.38	-0.43	-0.56	-0.16	-0.27
2022-03-31	-0.38	-0.43	-0.56	-0.23	-0.25
2021-12-31	-0.00	-0.00	-0.50	-0.26	0.06
2021-09-30	-0.15	-0.01	-0.14	0.21	0.00
2021-06-30	-0.01	-0.01	-0.00	0.51	0.06
2021-03-31	0.11	0.13	0.04	0.57	0.07
2020-12-31	0.27	0.44	0.08	0.62	0.08
2020-09-30	-0.50	-0.71	-0.24	0.44	-0.21

Gross Margins

Margin Kotor: The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.

Margin Keuntungan Bersih: Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.

Margin Operasi: Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.

Period End (TTM)	Margin Kotor	Margin Keuntungan Bersih	Margin Operasi
2025-06-30
2025-03-31	1.00	-109.85	-137.45
2024-12-31	1.00	-24.83	-54.83
2024-09-30	1.00	-32.01	-49.38
2024-06-30	1.00	-53.02	-44.71
2024-03-31	1.00	-53.02	-44.71
2023-12-31	1.00	8.42	6.80
2023-09-30	1.00	8.42	6.80
2023-06-30	1.12	8.42	6.80
2023-03-31	1.12	9.57	7.57
2022-12-31	0.40	47.40	37.78
2022-09-30	0.40	47.40	37.78
2022-06-30	0.47	-18.85	-15.27
2022-03-31	0.47	-22.05	-18.73
2021-12-31	1.00	-26.49	-22.74
2021-09-30	1.00	-0.42	-0.22
2021-06-30	1.00	-0.01	-0.12
2021-03-31	1.00	0.14	-0.01
2020-12-31	1.00	0.31	0.10
2020-09-30